Clinical study on Yunnan white ointment in the treatment of fibromyalgia syndrome

首次发布于 2026 年 7 月 13 日

Spectrophon LTD Glucometry Monitor Accuracy

计划入组 210 人 · 首次发布于 2017 年 12 月 2 日

POCARED Diagnostics, LTD, Field Study Protocol

计划入组 40,000 人 · 首次发布于 2011 年 12 月 7 日

Engineered skin substitute(Lonza Group AG)

Rap2B (Glaxo Group Ltd.)

3936W92 (Glaxo Group Ltd.)

Lonza Ltd.

Switzerland

Lonza Biologics Inc.

Switzerland

LONZA BIOLOGICS TUAS PTE. LTD.

Singapore

US Small Molecule API CDMO Market Projected to Reach $12.49 Billion by 2030 Driven by FDA Approvals and HPAPI Demand

Acumen and Lonza Expand Collaboration to Advance Sabirnetug for Alzheimer's Disease

Lonza Completes Strategic Transformation with $3 Billion Divestment of Capsules & Health Ingredients Business